
Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Development and validation of clinical screening systems for Cushing disease in the United States
Pituitary. 2025 Oct 10; 28:108
Body mass index and blood volume influence plasma biomarkers and positron emission tomography classification in preclinical Alzheimer's disease
Alzheimer's & dementia : the journal of the Alzheimer's Association. 2025 Oct ; 21:e70765
Current Concepts in Revascularization for Ischemic Heart Disease With Reduced Ejection Fraction
Circulation. Cardiovascular interventions. 2025 Sep 15; e014625
Update on Medical Treatment of Cushing's Syndrome
Drugs. 2025 Sep 15;
Drosophila and human cell studies reveal a conserved role for CEBPZ, NOC2L, and NOC3L in rRNA processing and tumorigenesis
Journal of cell science. 2025 Aug 19;
PTH stimulation of Rankl transcription is regulated by SIK2 and 3 and mediated by CRTC2 and 3 through action of protein phosphatases 1, 2, 4, and 5
Journal of biological chemistry. 2025 Jul 01; 110434
Baseline Characteristics of Weight-Loss Success in a Personalized Nutrition Intervention: A Secondary Analysis
Nutrients. 2025 Jun 30; 17:
Pituitary incidentaloma: a Pituitary Society international consensus guideline statement
Nature reviews. Endocrinology. 2025 Jun 24;